Ravi Kalyanaraman is a director at Bristol-Myers Squibb Company in Global Analytical Technology group with Global Product Development and Supply. He received his Ph.D. from the University of Idaho in 1996 and did his post-doctoral work at the University of Puerto Rico. He has been with Bristol-Myers Squibb since 2002. His work with Bristol-Myers Squibb has been focused on developing new and novel techniques to detect pharmaceutical counterfeits. His interests are mainly in using vibrational spectroscopic techniques, such as Raman, mid and Near-Infrared (NIR) for pharmaceutical counterfeit detection and for product authentication. He leads a team in global quality organization that is involved in the analysis of products received from complaints and from corporate security groups. He also leads a group that supports manufacturing investigations.